EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Evolution of WHO Influenza Antiviral Stockpile: Rapid Access and Use in Low- and Middle-Income Countries for Pandemic Preparedness and Response

Nahoko Shindo iD, Anne Huvos, Tim Nguyen

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiaf379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Nahoko Shindo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemic and Pandemic Management, WHO Heatlh Emergencies Programme, World Health Organization, Geneva, Switzerland. Hauptthemen laut MEDLINE: Antiviral Agents, Influenza, Human, Pandemics, Strategic Stockpile. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The SARS outbreak and influenza A(H5N1) infections (2003–2004) prompted WHO to establish a global influenza antiviral stockpile, enabling rapid distribution to 72 countries during the 2009 A(H1N1) pandemic. To improve access in low- and middle-income countries, WHO added antivirals to the WHO Model List of Essential Medicines and included them in the Prequalification Programme. The 2011 Pandemic Influenza Preparedness Framework refined strategies for equitable access and rapid response. Lessons from COVID-19 led to a new WHO-led mechanism—the Interim Medical Countermeasures Network (i-MCM-net)—which supports integrated supply chains, real-time data sharing, research and development, and equitable access. WHO continues to emphasise equity and global solidarity, highlighting the need for accessible, effective, and affordable antivirals alongside vaccines to protect vulnerable populations and mitigate the impact of future pandemics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsInfluenza, HumanPandemicsStrategic StockpileHumansWorld Health OrganizationDeveloping CountriesCOVID-19Global HealthHealth Services AccessibilitySARS-CoV-2Pandemic Preparedness

Stichwörter der Autor:innen

WHO essential medicines & prequalificationantiviral stockpile strategyequitable access in LMICinfluenza pandemic preparednessmedical counternmeasures network (i-MCM-net)

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Department of Epidemic and Pandemic Management, WHO Heatlh Emergencies Programme, World Health Organization, Geneva, Switzerland.

ORCID-Profile: Nahoko Shindo

Förderung

  • World Health Organization

Zitieren

APA

Shindo, N., Huvos, A., & Nguyen, T. (2025). Evolution of WHO Influenza Antiviral Stockpile: Rapid Access and Use in Low- and Middle-Income Countries for Pandemic Preparedness and Response. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf379

Vancouver

Shindo N, Huvos A, Nguyen T. Evolution of WHO Influenza Antiviral Stockpile: Rapid Access and Use in Low- and Middle-Income Countries for Pandemic Preparedness and Response. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf379

BibTeX
@article{Shindo2025,
  author = {Shindo, Nahoko and Huvos, Anne and Nguyen, Tim},
  title = {Evolution of WHO Influenza Antiviral Stockpile: Rapid Access and Use in Low- and Middle-Income Countries for Pandemic Preparedness and Response},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiaf379}
}
Kostenlos starten →